AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra's obesity drug. AI takes center stage at HIMSS ...

WESH 2's Jason Guy and Orlando Health Weight Loss & Bariatric Surgery Institute surgeon, Dr. Muhammad Ghanem, discuss potential influences on the downward trend ...

Most obese patients grow resistant to satiety signals from the hormone leptin. A new study shows that leptin sensitivity can be restored in mice, leading to weight loss.

Over half of all adults — and a third of children and young adults — around the world are expected to be overweight or obese ...

Penn State has eight wrestlers ranked first or second in the country entering the 2025 Big Ten Wrestling Championships.

Getting enough fiber can help with weight loss goals. Here's how much fiber you should eat per day if you want to lose weight ...

AbbVie's strategic move into the obesity market through a partnership with Gubra A/S shows potential but won't impact revenue ...

Discover what happens to your body when you cut carbs, from rapid weight loss to brain shifts and metabolic changes.

Copyright © 2025 Bleacher Report, Inc. A Warner Bros. Discovery Company. All Rights Reserved.

Insurance coverage for GLP-1 drugs remains tight despite rising demand, with more patients facing restrictions or paying out ...

A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.

Health-care professionals, eager to support their patients diagnosed with diabetes or obesity, are writing more prescriptions ...